Single cell characteristics of patients with vaccine-related adverse reactions following inactivated COVID-19 vaccination
Description
A good safety and immunogenicity profile was reported in Phase I and II clinical trials of inactivated SARS-CoV-2 vaccines. Here, we report two cases associated with vaccine-associated adverse events, including one patient with fever and another with
